Omron Healthcare, which makes blood pressure monitors, gave a first look at its “Project Zero” Wrist and Upper Arm Blood Pressure Monitors and its OMRON Connect app at the Consumer Electronic Show in ...
Blood pressure monitor maker Omron Healthcare has gotten approval for a new home monitor that can detect atrial fibrillation, or a-fib. The company uses a novel machine-learning algorithm, called ...
- Reinforcing Commitment to Preventive Cardiovascular and Home Blood Pressure Monitoring - The journey began over half a century ago, with the launch of the first OMRON-branded BPM in 1973, when all ...
"Progress made in reducing heart attack deaths provides a roadmap to address rising mortality rates from arrythmias, heart failure and hypertensive heart disease" HOFFMAN ESTATES, Ill., July 3, 2025 ...
- Pilot Project on Home-based Heart Failure ICT Monitoring -- Using Vital Data to Enable Early Medical Intervention - KYOTO, Japan, July 31, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd., the ...
Hypertension Plus in the U.K., VitalSight™ in the U.S., Recognized as Outstanding Health Technology at World’s Largest Innovation Show HOOFDDORP, Netherlands--(BUSINESS WIRE)--OMRON Healthcare, Inc., ...
OMRON Healthcare has been designing state of the art blood pressure monitors for over 50 years. And today, our passion to empower people to take charge of their health – using precise technology in ...
Japan-based medical device company Omron Healthcare has partnered with AliveCor to help bring AliveCor's FDA-cleared smartphone-connected electrocardiogram (ECG) to more online and brick and mortar ...
TOKYO, Dec. 11, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global electrocardiogram (ECG) business strategy, positioning it as a key driver of the ...
Expert judges determining the best of the best in healthcare innovation recognized OMRON Healthcare for its blood pressure monitors with AI-powered AFib detection HOFFMAN ESTATES, Ill., Oct. 28, 2025 ...
Omron is undervalued by 31%, presenting a strong buy opportunity due to excessive market pessimism and resilient fundamentals in automation and healthcare. The company boasts leading positions in ...